pentoxyl has been researched along with Myelodysplastic Syndromes in 1 studies
*Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abakir, A; Gackowski, D; Gawronski, M; Kerr, C; Maciejewski, JP; Olinski, R; Radivoyevitch, T; Ruzov, A; Starczak, M; Zarakowska, E | 1 |
1 other study(ies) available for pentoxyl and Myelodysplastic Syndromes
| Article | Year |
|---|---|
5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.
Topics: Biomarkers; Cytosine; Dioxygenases; DNA-Binding Proteins; Humans; Mutation; Myelodysplastic Syndromes; Pentoxyl; Phosphoproteins; Proto-Oncogene Proteins; RNA Splicing Factors | 2020 |